首页 > 市场调查报告书 > 医疗设备

心血管设备

心臟节律管理设备市场规模、份额及成长分析（按产品、最终用户及地区划分）－2026-2033年产业预测

市场调查报告书

商品编码

1899431

心臟节律管理设备市场规模、份额及成长分析（按产品、最终用户及地区划分）－2026-2033年产业预测

Cardiac Rhythm Management Devices Market Size, Share, and Growth Analysis, By Product (Pacemakers [Implantable, External]), By End User (Hospitals & Clinics, Ambulatory Surgery Centers), By Region - Industry Forecast 2026-2033

出版日期: 2025年12月16日 | 出版商:

SkyQuest | 英文 157 Pages | 商品交期: 3-5个工作天内

价格

简介目录

预计到 2024 年，心臟节律管理设备市场规模将达到 209.2 亿美元，到 2025 年将达到 220.7 亿美元，到 2033 年将达到 338.7 亿美元，预测期（2026-2033 年）的复合年增长率为 5.5%。

心血管疾病盛行率的不断上升以及全球治疗手术数量的增加，预计将显着推动心臟节律管理设备的销售。在心臟研发投入不断增长的推动下，技术的创新进步可望进一步提升市场前景。远端监测和远端医疗医疗的日益普及也将进一步刺激对这些设备的需求。此外，新兴市场医疗费用支出的成长以及对医疗基础设施建设的日益重视，将为产业相关人员创造新的机会。微创心血管手术的趋势也将促进此类设备的更广泛应用。然而，电池续航力有限、设备更换需求、故障风险以及新兴地区认知度较低等挑战，可能会阻碍市场的成长潜力。

心臟节律管理设备市场驱动因素

患者对微创心血管手术的偏好显着提升，这对心臟节律管理设备市场产生了积极影响。这种对微创治疗方案日益增长的需求与心臟节律管理技术的进步相契合。透过微创技术植入这些设备将更加便捷，预计这将随着时间的推移显着提升市场需求。随着患者对能够最大限度减少不适感和缩短恢復期的治疗方法方案的需求不断增长，心臟节律管理设备市场有望受益于以患者为中心、高效治疗方法的持续发展趋势。

心臟节律管理设备市场的限制因素

由于设备故障和失效的风险，心臟节律管理设备市场面临严峻挑战，这会削弱患者的信心，并导致监管机构加强审查。这些问题不仅加剧了患者对这些技术可靠性的担忧，还可能阻碍未来的销售前景。随着监管机构着手解决这些问题并实施更严格的指导方针和监管，人们对心臟节律管理解决方案的整体信心可能会下降，进一步影响市场成长和普及。解决这些薄弱环节对于维持产业发展动能至关重要。

心臟节律管理设备市场趋势

心臟节律管理设备市场日益关注改善心臟衰竭患者的治疗效果，这主要得益于其监测关键生理参数（例如体液储存）的能力。这项创新技术使医疗专业人员能够更有效地追踪心臟健康状况，从而及时进行干预，防止心臟衰竭进展并降低死亡率。人们对早期发现和管理心臟相关疾病重要性的认识不断提高，预计将增加对心臟护理领域先进监测解决方案的需求。这有望推动市场成长，并促进设备功能和患者管理策略的创新。

起搏器
- 可植入式
- 外部的
去心房颤动
- 植入式心臟整流去颤器（ICD）
- S-ICD
- T-ICD
- 体外去心房颤动
- 手动体外心臟去心房颤动
- 自动体外心臟去心房颤动
- 穿戴式去心房颤动
- 心臟再同步治疗（CRT）
- CRT去心房颤动
- CRT心律调节器

按最终用户分類的心臟节律管理设备市场

医院和诊所
门诊手术中心
其他的

按地区分類的心臟节律管理设备市场规模

北美洲
- 美国
- 加拿大
欧洲
- 德国
- 西班牙
- 法国
- 英国
- 义大利
- 其他欧洲地区
亚太地区
- 中国
- 印度
- 日本
- 韩国
- 亚太其他地区
拉丁美洲
- 巴西
- 其他拉丁美洲地区
中东和非洲（MEA）
- 海湾合作委员会国家
- 南非
- 其他中东和非洲地区

竞争格局

前五大公司对比
主要企业的市场定位（2025 年）
主要市场参与者所采取的策略
近期市集活动
主要企业市占率（2025 年）

主要企业简介

Physio-Control, Inc.（Stryker）（US）
BIOTRONIK（Germany）
Schiller（Switzerland）
Medtronic（US）
Abbott（US）
Koninklijke Philips NV（Netherlands）
Zoll Medical Corporation（US）
Boston Scientific Corporation（US）
Progetti Srl（Italy）
LivaNova Plc（UK）
Impella（ABIOMED, US）
AngioDynamics, Inc.（US）
MicroPort Scientific Corporation（China）
Edwards Lifesciences Corporation（US）
Getinge AB（Sweden）
Synchrony Medical（US）
Osypka AG（Germany）
Inspire Medical Systems, Inc.（US）
AtriCure, Inc.（US）
Apex Medical（Taiwan）
Biotronik SE & Co. KG（Germany）
VivaSonic Inc.（US）

简介目录

Product Code: SQMIG35A2577

Cardiac Rhythm Management Devices Market size was valued at USD 20.92 Billion in 2024 and is poised to grow from USD 22.07 Billion in 2025 to USD 33.87 Billion by 2033, growing at a CAGR of 5.5% during the forecast period (2026-2033).

The increasing prevalence of cardiovascular disorders, coupled with a rising number of treatment procedures globally, is anticipated to significantly boost sales of cardiac rhythm management devices. Innovative advancements in technology, driven by heightened investment in cardiac research and development, are likely to enhance market prospects. The growing adoption of remote monitoring and telehealth practices will further stimulate demand for these devices. Additionally, increased healthcare spending and a focus on healthcare infrastructure improvements in emerging markets will create new opportunities for industry players. The trend towards minimally invasive cardiac procedures will also facilitate broader adoption. However, challenges such as battery limitations, device replacement needs, malfunction risks, and low awareness in emerging regions may hinder market growth potential.

Top-down and bottom-up approaches were used to estimate and validate the size of the Cardiac Rhythm Management Devices market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Cardiac Rhythm Management Devices Market Segments Analysis

Global Cardiac Rhythm Management Devices Market is segmented by Product, End User, and region. Based on Product, the market is segmented into Pacemakers, and Defibrillators. Based on End User, the market is segmented into Hospitals & Clinics, Ambulatory Surgery Centers, and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.

Driver of the Cardiac Rhythm Management Devices Market

There has been a notable shift towards a preference for minimally invasive cardiac procedures among patients, which positively impacts the cardiac rhythm management devices sector. This growing inclination towards less invasive options aligns seamlessly with the advancements in cardiac rhythm management technologies. The ability to easily implant these devices through minimally invasive methods is anticipated to significantly enhance their demand over time. As patients increasingly seek out solutions that minimize discomfort and recovery time, the market for cardiac rhythm management devices is expected to benefit from this ongoing trend towards more patient-centric and efficient treatment options.

Restraints in the Cardiac Rhythm Management Devices Market

The cardiac rhythm management devices market faces significant challenges due to the risk of device failures and malfunctions, which can undermine patient confidence and lead to increased regulatory scrutiny. Such issues not only contribute to apprehension among patients regarding the reliability of these technologies but may also hinder future sales prospects. As regulatory bodies impose stricter guidelines and oversight in response to these concerns, the overall trust in cardiac rhythm management solutions may diminish, further impacting market growth and adoption rates. Addressing these vulnerabilities is crucial for sustaining momentum within the industry.

Market Trends of the Cardiac Rhythm Management Devices Market

The Cardiac Rhythm Management Devices market is increasingly focusing on enhancing patient outcomes for those with heart failure, driven by the capability of these devices to monitor critical physiological parameters, such as fluid accumulation. This innovative technology allows healthcare professionals to track cardiac health more effectively, leading to timely interventions that can prevent the progression of heart failure and reduce mortality rates. As awareness grows regarding the importance of early detection and management of heart-related issues, the demand for advanced monitoring solutions in cardiac care is expected to rise, thereby propelling market growth and driving innovations in device functionality and patient management strategies.

Introduction

Objectives of the Study
Definitions
Market Scope

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Market Overview Outlook
Supply Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers

Key Market Insights

Technology Analysis
Pricing Analysis
Value Chain Analysis
Ecosystem of the Market
Trade Analysis
Supply chain Analysis
Case study Analysis
Patent Analysis
Customer & Buying Criteria Analysis
Regulatory Landscape
Innovation Matrix
Top Investment Analysis
Key Success Factor
Degree of Competition

Cardiac Rhythm Management Devices Market by Product

Market Overview
Pacemakers
- Implantable
- External
Defibrillators
- Implantable Cardioverter Defibrillators (ICD)
- S-ICD
- T-ICD
- External Defibrillator
- Manual External Defibrillator
- Automatic External Defibrillator
- Wearable Cardioverter Defibrillator
- Cardiac Resynchronization Therapy (CRT)
- CRT-Defibrillator
- CRT-Pacemakers

Cardiac Rhythm Management Devices Market by End User

Market Overview
Hospitals & Clinics
Ambulatory Surgery Centers
Others

Cardiac Rhythm Management Devices Market Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Activities in the Market
Key Companies Market Share (%), 2025

Key Company Profiles

Physio-Control, Inc. (Stryker) (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
BIOTRONIK (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Schiller (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Medtronic (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Abbott (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Koninklijke Philips N.V. (Netherlands)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Zoll Medical Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Boston Scientific Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Progetti Srl (Italy)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
LivaNova Plc (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Impella (ABIOMED, US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
AngioDynamics, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
MicroPort Scientific Corporation (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Edwards Lifesciences Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Getinge AB (Sweden)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Synchrony Medical (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Osypka AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Inspire Medical Systems, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
AtriCure, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Apex Medical (Taiwan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Biotronik SE & Co. KG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
VivaSonic Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments